Don’t miss outtag icon
Get early access to Digital 100 2026, Similarweb’s official ranking of the fastest-growing brandsPre-register now!banner icon
MaxCyte

November 2025

MaxCyte Market Share Analysis for November 2025

Our collection of ExPERT™ instruments delivers engineering excellence by combining high efficiency and cell viability with seamless scalability.
Year Founded1999
Employees51 - 200
Annual Revenue$25M - $50M
maxcyte.com
MaxCyte
MaxCyte (including company regionals)
  • maxcyte.com
    maxcyte.com
See more website traffic and engagement information

MaxCyte Revenue up to November 2025 is 25M - 50M

revenue generated by MaxCyte top domains

MaxCyte top domains revenue over 3 years

Revenue for MaxCyte top domains


Total visits to MaxCyte's top domains

Understand MaxCyte market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in MaxCyte's top domains

Analyze MaxCyte engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on MaxCyte's top domains

See how MaxCyte keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by MaxCyte

These are the website technologies, by industry, used by MaxCyte top domains

Advertising (9)

Google Adsense

Google Adsense

Conversion & Analytics (9)

Google Analytics

Google Analytics

Payment & Currencies (8)

Cart Functionality

Cart Functionality

Widget (6)

Twemoji

Twemoji

More Technologies

16

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from MaxCyte

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMaxCyte partnered with Moonlight Bio, Inc. on Oct 6th '25.ROCKVILLE, Md., Oct. 06, 2025 (GLOBE NEWSWIRE) - MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics, today announced the signing of a Strategic Platform License (SPL) agreement with Moonlight Bio, a preclinical-stage biotechnology company based in Seattle, Washington.
NewsMaxCyte is developing off-the-shelf T-cell therapies.Auspicious alliance: MaxCyte and Adicet partner to develop off-the-shelf T-cell therapies.

See all MaxCyte signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.